{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:31:12Z","timestamp":1794447072583,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Korea government","award":["2022R1C1C1004347"],"award-info":[{"award-number":["2022R1C1C1004347"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study evaluated the treatment outcomes of spine stereotactic body radiation therapy (SBRT) in sarcoma patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A total of 44 sarcoma patients and 75 spinal lesions (6 primary tumors, 69 metastatic tumors) treated with SBRT were retrospectively reviewed between 2006 and 2017. The median radiation dose was 33\u00a0Gy (range, 18\u201345\u00a0Gy) in 3 fractions (range, 1\u20135) prescribed to the 75% isodose line.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median follow-up duration was 18.2\u00a0months. The 1-year local control was 76.4%, and patients treated with single vertebral body were identified as a favorable prognostic factor on multivariate analyses. Progression-free survival at 1\u00a0year was 31.9%, with the interval between initial diagnosis and SBRT and extent of disease at the time of treatment being significant prognostic factors. The 1-year overall survival was 80.5%, and PTV and visceral metastases were independently associated with inferior overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SBRT for spinal sarcoma is effective in achieving local control, particularly when treating a single vertebral level with a limited extent of disease involvement, resulting in an excellent control rate. The extent of disease at the time of SBRT is significantly correlated with survival outcomes and should be considered when treating spine sarcoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-023-02346-w","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T03:02:02Z","timestamp":1695351722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0565-9301","authenticated-orcid":false,"given":"Eunji","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7459-6316","authenticated-orcid":false,"given":"Mi-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyung","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ung-Kyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8753-9831","authenticated-orcid":false,"given":"Chang-Bae","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"113","key":"2346_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"2021","author":"M Sbaraglia","year":"2020","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2020;2021(113):70\u201384.","journal-title":"Pathologica"},{"key":"2346_CR3","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.3390\/cancers13194775","volume":"13","author":"NK Shah","year":"2021","unstructured":"Shah NK, Yegya-Raman N, Jones JA, Shabason JE. Radiation therapy in metastatic soft tissue sarcoma: from palliation to ablation. Cancers. 2021;13:4775. https:\/\/doi.org\/10.3390\/cancers13194775.","journal-title":"Cancers"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"107327481881550","DOI":"10.1177\/1073274818815504","volume":"25","author":"AO Naghavi","year":"2018","unstructured":"Naghavi AO, Yang GQ, Latifi K, Gillies R, McLeod H, Harrison LB. The future of radiation oncology in soft tissue sarcoma. Cancer Control. 2018;25:1073274818815504.","journal-title":"Cancer Control"},{"key":"2346_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.31616\/asj.2020.0379","volume":"14","author":"SY Chang","year":"2020","unstructured":"Chang SY, Mok S, Park SC, Kim H, Chang BS. Treatment strategy for metastatic spinal tumors: a narrative review. Asian Spine J. 2020;14:513\u201325.","journal-title":"Asian Spine J"},{"key":"2346_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.31616\/asj.2022.0367","volume":"16","author":"SH Hong","year":"2022","unstructured":"Hong SH, Chang BS, Kim H, Kang DH, Chang SY. An updated review on the treatment strategy for spinal metastasis from the spine surgeon\u2019s perspective. Asian Spine J. 2022;16:799\u2013811.","journal-title":"Asian Spine J"},{"key":"2346_CR7","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1002\/cncr.27530","volume":"118","author":"AK Garg","year":"2012","unstructured":"Garg AK, Shiu AS, Yang J, Wang XS, Allen P, Brown BW, et al. Phase 1\/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer. 2012;118:5069\u201377.","journal-title":"Cancer"},{"key":"2346_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3171\/2016.1.SPINE151166","volume":"25","author":"JC Ho","year":"2016","unstructured":"Ho JC, Tang C, Deegan BJ, Allen PK, Jonasch E, Amini B, et al. The use of spine stereotactic radiosurgery for oligometastatic disease. J Neurosurg Spine. 2016;25:239\u201347.","journal-title":"J Neurosurg Spine"},{"key":"2346_CR9","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2016.9.FOCUS16369","volume":"42","author":"Y Yamada","year":"2017","unstructured":"Yamada Y, Katsoulakis E, Laufer I, Lovelock M, Barzilai O, McLaughlin LA, et al. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus. 2017;42:E6.","journal-title":"Neurosurg Focus"},{"key":"2346_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.ijrobp.2013.12.042","volume":"88","author":"MR Folkert","year":"2014","unstructured":"Folkert MR, Bilsky MH, Tom AK, Oh JH, Alektiar KM, Laufer I, et al. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine. Int J Radiat Oncol Biol Phys. 2014;88:1085\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2346_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1533034616643221","volume":"16","author":"JA Miller","year":"2017","unstructured":"Miller JA, Balagamwala EH, Angelov L, Suh JH, Djemil T, Magnelli A, et al. Stereotactic radiosurgery for the treatment of primary and metastatic spinal sarcomas. Technol Cancer Res Treat. 2017;16:276\u201384.","journal-title":"Technol Cancer Res Treat"},{"key":"2346_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2017.1.SPINE161045","volume":"27","author":"AJ Bishop","year":"2017","unstructured":"Bishop AJ, Tao R, Guadagnolo BA, Allen PK, Rebueno NC, Wang XA, et al. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine. 2017;27:303\u201311.","journal-title":"J Neurosurg Spine"},{"key":"2346_CR13","first-page":"24","volume":"7","author":"E Elibe","year":"2018","unstructured":"Elibe E, Boyce-Fappiano D, Ryu S, Siddiqui S, Lee I, Rock J, et al. Stereotactic radiosurgery for primary and metastatic sarcomas of the spine. Appl Rad Oncol. 2018;7:24\u201332.","journal-title":"Appl Rad Oncol"},{"key":"2346_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3171\/2015.11.SPINE151059","volume":"25","author":"JE Leeman","year":"2016","unstructured":"Leeman JE, Bilsky M, Laufer I, Folkert MR, Taunk NK, Osborne JR, et al. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study. J Neurosurg Spine. 2016;25:52\u20138.","journal-title":"J Neurosurg Spine"},{"key":"2346_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11060-011-0777-0","volume":"107","author":"UK Chang","year":"2012","unstructured":"Chang UK, Cho WI, Lee DH, Kim MS, Cho CK, Lee SY, et al. Stereotactic radiosurgery for primary and metastatic sarcomas involving the spine. J Neurooncol. 2012;107:551\u20137.","journal-title":"J Neurooncol"},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1667\/RADE-20-00226.1","volume":"196","author":"R Haas","year":"2021","unstructured":"Haas R, Floot B, Scholten A, van der Graaf W, van Houdt W, Schrage Y, et al. Cellular radiosensitivity of soft tissue sarcoma. Radiat Res. 2021;196:23\u201330.","journal-title":"Radiat Res"},{"key":"2346_CR17","doi-asserted-by":"crossref","first-page":"175883592110706","DOI":"10.1177\/17588359211070646","volume":"14","author":"MJ Spa\u0142ek","year":"2022","unstructured":"Spa\u0142ek MJ, Teterycz P, Borkowska A, Poleszczuk J, Rutkowski P. Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence. Therap Adv Med Oncol. 2022;14:17588359211070646.","journal-title":"Therap Adv Med Oncol"},{"key":"2346_CR18","doi-asserted-by":"publisher","first-page":"87367","DOI":"10.1155\/SRCM\/2006\/87367","volume":"2006","author":"W Rhomberg","year":"2006","unstructured":"Rhomberg W. The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane. Sarcoma. 2006;2006:87367.","journal-title":"Sarcoma"},{"key":"2346_CR19","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.1158\/0008-5472.CAN-05-0656","volume":"65","author":"JF Torres-Roca","year":"2005","unstructured":"Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, McCarthy S, et al. Prediction of radiation sensitivity using a gene expression classifier. Can Res. 2005;65:7169\u201376.","journal-title":"Can Res"},{"key":"2346_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ijrobp.2009.05.056","volume":"75","author":"S Eschrich","year":"2009","unstructured":"Eschrich S, Zhang H, Zhao H, Boulware D, Lee J-H, Bloom G, et al. Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J Radiat Oncol Biol Phys. 2009;75:497\u2013505.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2346_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ijrobp.2009.06.014","volume":"75","author":"SA Eschrich","year":"2009","unstructured":"Eschrich SA, Pramana J, Zhang H, Zhao H, Boulware D, Lee J-H, et al. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. Int J Radiat Oncol Biol Phys. 2009;75:489\u201396.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2346_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","volume":"18","author":"JG Scott","year":"2017","unstructured":"Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. 2017;18:202\u201311.","journal-title":"Lancet Oncol"},{"key":"2346_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101165","volume":"14","author":"G Yang","year":"2021","unstructured":"Yang G, Yuan Z, Ahmed K, Welsh EA, Fulp WJ, Gonzalez RJ, et al. Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization. Transl Oncol. 2021;14: 101165.","journal-title":"Transl Oncol"},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-11013-y","volume":"23","author":"S Roohani","year":"2023","unstructured":"Roohani S, Loskutov J, Heufelder J, Ehret F, Wedeken L, Regenbrecht M, et al. Photon and proton irradiation in patient-derived, three-dimensional soft tissue sarcoma models. BMC Cancer. 2023;23:1\u201310.","journal-title":"BMC Cancer"},{"key":"2346_CR25","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1016\/S1470-2045(13)70101-3","volume":"14","author":"A Sahgal","year":"2013","unstructured":"Sahgal A, Whyne CM, Ma L, Larson DA, Fehlings MG. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases. Lancet Oncol. 2013;14:e310\u201320.","journal-title":"Lancet Oncol"}],"updated-by":[{"DOI":"10.1186\/s13014-023-02358-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000}}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02346-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T07:06:49Z","timestamp":1700464009000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02346-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02346-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3034673\/v1","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13014-023-02358-6","URL":"https:\/\/doi.org\/10.1186\/s13014-023-02358-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Korea Cancer Center Hospital. Informed consent was not required due to the nature of retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}